PR Newswire - Private Equity's AI Moment: The Greatest Value Lev...
The following article is authored by Neil Dhar, Senior Vice President, IBM Consulting Americas ARMON...
Read morePR Newswire - Ispire Technology Inc. Schedules Fiscal Third Quar...
LOS ANGELES, May 1, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (...
Read morePR Newswire - CCTV+: Hello, Beijing! Exploring the City Under Ch...
BEIJING, May 1, 2026 /PRNewswire/ -- China is drawing a growing number of international visitors to ...
Read morePR Newswire - SC Joins Forces with "Thai Longstay Management" to...
BANGKOK, May 1, 2026 /PRNewswire/ -- SC is driving Thailand's ambition to become a global residentia...
Read morePR Newswire - Hong Kong Anti-Fraud Alliance Platform Officially ...
Uniting Social and Technological Forces to Advance Anti-Fraud Efforts from Advocacy to Action HONG K...
Read morePR Newswire - ADGM Announces Rokos Capital Management's Abu Dhab...
ABU DHABI, UAE, May 1, 2026 /PRNewswire/ -- ADGM, the international financial centre of Abu D...
Read morePR Newswire - Dreame Launches Three World-First Air and Environm...
SAN FRANCISCO, May 1, 2026 /PRNewswire/ -- Dreame Home Environmental Appliances today launched three...
Read morePR Newswire - TCL TECH 2025 Net Profit Surges 188.8%, Led by Str...
SHENZHEN, China, May 1, 2026 /PRNewswire/ -- TCL Technology Group Corporation (000100.SZ) rep...
Read morePR Newswire - Malaysian Treasure Singer Shila Amzah Stuns as Hea...
KUALA LUMPUR, Malaysia and WUHU, China, May 1, 2026 /PRNewswire/ -- Tailored to resonate with young ...
Read morePR Newswire - XPENG Announces Vehicle Delivery Results for April...
GUANGZHOU, China, May 1, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and H...
Read morePR Newswire - The 6th Asian Beach Games Sanya 2026 conclude succ...
SANYA, China, May 1, 2026 /PRNewswire/ -- On the evening of April 30, 2026, the closing ceremony of ...
Read morePR Newswire - Restore Vision Announces First-in-Human Clinical I...
Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with...
Read more

ภาษาไทย
English